FDA label

What is Neurontin used for?

Neurontin contains gabapentin. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.

Source: DailyMed SPL label file dated 2026-10-23. Publisher page

The FDA label says: “NEURONTIN® is indicated for: Management of postherpetic neuralgia in adults; Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy.”

Run it in Rivvi

Which 2027 plans near you dropped or restricted Neurontin?

Tier changes and new prior auth, step therapy or quantity limits, plan by plan.

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Neurontin, capsule

Indications and Usage, quoted from the label by Viatris Specialty LLC (NDA020235). Cross-references to other label sections are left out.

NEURONTIN® is indicated for:

  • Management of postherpetic neuralgia in adults
  • Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy

Source: DailyMed label, set id 97935fd9-1d4a-43b6-a5d9-de994591187b, version 48, effective May 12, 2026. NDC 58151-281, one of 4 listings for this product.

Questions

What is Neurontin used for?

The FDA label says: “NEURONTIN® is indicated for: Management of postherpetic neuralgia in adults; Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy.”

Does this page cover off-label uses or dosing?

No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.

More on Neurontin

Try it on your own data today.

Free to start. Most teams are using it the same day.